| For: | Dorobantu M, Popa-Fotea NM, Popa M, Rusu I, Micheu MM. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. World J Stem Cells 2017; 9(12): 203-218 [PMID: 29321822 DOI: 10.4252/wjsc.v9.i12.203] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i12/203.htm |
| Number | Citing Articles |
| 1 |
Hoda Madani, Sara Pahlavan, Massoud Vosough, Maryam Barekat, Kiara Rezaei-kalantari, Nasser Aghdami, Ali Akbar Zeinaloo. A HEART-WISE: Allogeneic Wharton’s Jelly-derived Mesenchymal Stromal Cells’ Intracoronary Transplantation in Pediatric Patients with Dilated Cardiomyopathy: The First Case Reports. BMC Cardiovascular Disorders 2026; 26(1) doi: 10.1186/s12872-026-05866-x
|
| 2 |
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight. Cells 2018; 7(12) doi: 10.3390/cells7120255
|
| 3 |
K. V. Dergilev, Iu. D. Vasilets, Z. I. Tsokolaeva, E. S. Zubkova, E. V. Parfenova. Perspectives of cell therapy for myocardial infarction and heart failure based on cardiosphere cells. Terapevticheskii arkhiv 2020; 92(4) doi: 10.26442/00403660.2020.04.000634
|
| 4 |
Miruna Mihaela Micheu. Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?. World Journal of Stem Cells 2019; 11(8): 445-451 doi: 10.4252/wjsc.v11.i8.445
|
| 5 |
Babak Arjmand, Mina Abedi, Maryam Arabi, Sepideh Alavi-Moghadam, Mostafa Rezaei-Tavirani, Mahdieh Hadavandkhani, Akram Tayanloo-Beik, Ramin Kordi, Peyvand Parhizkar Roudsari, Bagher Larijani. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.704903
|